Diabetes Mellitus, Type 1 Clinical Trials
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
E
Recruiting
- Diabetes Mellitus, Type 1
- Toronto, Ontario, CanadaLMC Clinical Research Inc. (Bayview)
2022-04-06
Apr 6, 2022M
Not yet recruiting
- Diabetes Mellitus, Type 1
- LovedBy App
- Manchester, United KingdomManchester University NHS Foundation Trust
2022-04-07
Apr 7, 2022K
Not yet recruiting
- Diabetes Mellitus
- +10 more
- COMPASS: digital CBT
- London, United KingdomKing's College London
2022-04-06
Apr 6, 2022K
Active, not recruiting
- Diabetes Mellitus, Type 1
- Youth Empowerment Skills
- Waiting-list control
- London, United Kingdom
- +4 more
2022-03-29
Mar 29, 2022Y
Not yet recruiting
- Diabetes Mellitus, Type 1
- (no location specified)
2022-03-30
Mar 30, 2022N
Completed
- Diabetes Mellitus, Type 1
- Stockholm, SwedenNovo Nordisk Investigational Site
2022-04-06
Apr 6, 2022M
Recruiting
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Afrezza
- +2 more
- Los Angeles, California
- +16 more
2022-04-04
Apr 4, 2022L
Not yet recruiting
- Diabetes Mellitus, Type 2
- Diabetes Mellitus, Type 1
- Hyperbaric Oxygen
- (no location specified)
2022-04-04
Apr 4, 2022U
Recruiting
- Diabetes Mellitus, Type 1
- Miami, FloridaUniversity of Miami Miller School of Medicine Transplant Clinic
2022-04-04
Apr 4, 2022M
Recruiting
- Diabetes Mellitus, Type 1
- +2 more
- Bacillus Calmette-Guérin
- Saline Injection
- Charlestown, MassachusettsImmunobiology Labs CNY 149
2022-03-22
Mar 22, 2022U
Recruiting
- Diabetes Mellitus, Type 1
- Plerixafor
- +4 more
- Edmonton, Alberta, CanadaUniversity of Alberta
2022-04-01
Apr 1, 2022C
Recruiting
- Diabetes Mellitus
- +6 more
- VCTX210A unit
- Edmonton, Alberta, Canada
- +2 more
2022-04-01
Apr 1, 2022U
Recruiting
- Diabetes
- Diabetes Mellitus, Type 1
- Controlled hypoglycaemic state while driving
- Bern, SwitzerlandUniversity Department of Endocrinology, Diabetology, Clinical Nu
2022-03-24
Mar 24, 2022S
Active, not recruiting
- Diabetes Mellitus
- +2 more
- Eversense® CGM system
- Newport Beach, California
- +16 more
2022-03-31
Mar 31, 2022D
Recruiting
- Diabetes Mellitus, Type 1
- +10 more
- Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
- +2 more
- Hradec Kralove, Czechia
- +30 more
2022-03-17
Mar 17, 2022U
Recruiting
- Diabetes Mellitus, Type 1
- Islet cells
- Islet transplantation into the gastrointestinal submucosa
- San Francisco, CaliforniaUniversity of California, San Francisco
2022-03-29
Mar 29, 2022M
Recruiting
- Diabetes Mellitus, Type 1
- Mesenchymal Stem Cells (MSCs)
- Placebo Infusion (Plasmalyte A with 0.5% human serum albumin)
- Charleston, South CarolinaMedical University of South Carolina
2022-03-23
Mar 23, 2022I
Terminated
- Diabetes Mellitus, Type 1
- BiAP
- ABC4D
- London, United KingdomImperial College Clinical Research Facility
2022-03-29
Mar 29, 2022I
Completed
- Diabetes Mellitus, Type 1
- +2 more
- Dexcom G6 CGM
- Tandem t:slim X2 Insulin Pump
- London, United KingdomImperial College Clinical Research Facility
2022-03-29
Mar 29, 2022T
Active, not recruiting
- Diabetes Mellitus, Type 1
- t:slim X2 pump with Control-IQ technology
- San Diego, CaliforniaTandem Diabetes
2022-03-25
Mar 25, 2022Y
Completed
- Diabetes Mellitus, Type 1
- YpsoPump® insulin pump system
- Ulm, Germany
- +1 more
2022-03-21
Mar 21, 2022L
Not yet recruiting
- Diabetes Mellitus, Type 1
- Diabetes Mellitus, Type 2
- Diabetes LIVE JustICE
- Enhanced Education
- (no location specified)
2022-03-09
Mar 9, 2022S
Not yet recruiting
- Diabetes Mellitus, Type 1
- Sohag, EgyptFaculty of medicine Sohag University
2022-03-09
Mar 9, 2022H
Active, not recruiting
- Diabetes Mellitus, Type 1
- HIGH INTENSITY INTERVAL TRAINING
- Talcahuano, Concepcion, ChileHospital Las Higueras
2022-03-15
Mar 15, 2022M
Recruiting
- Diabetic Kidney Disease
- +7 more
- Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Lower Dose
- Autologous adipose-derived mesenchymal stem/stromal cells (MSC) Higher Dose
- Rochester, MinnesotaMayo Clinic in Rochester
2022-03-11
Mar 11, 2022